Medication Overuse Headache (MOH). Other headache syndromes
Conditions
Interventions
Intervention 1: Intervention group: celecoxib (100 mg, Cap, Iran, Tehran, Daru Pars, celecoxib 100 mg three times daily for the first five days, 100 mg twice daily (five days later) and 100 mg once a
Sponsors
Oroumia University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: age between 18 to50 year Patients with headache more than 15 days per month A history of regular use of one or more symptomatic treatment medications over a period of more than a month, including ergotamine, tryptan, combination of analgesic drugs (simple and combination), tryptones, ergotamine and narcotics (more than 10 days per month for more than 3 months), or analgesic drugs Simple such as acetaminophen or NSAIDs (10 days per month in regular three months) A headache that progresses or gets worse in the course of drug abuse lack of mental psychological illness no pregnancy No previous history or disease has been detected not having platelet disorders
Exclusion criteria
Exclusion criteria: lack of referral for the follow up Arbitrary discontinuation of patient medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Headache severity. Timepoint: 15 days. Method of measurement: VAS.;Headache duration. Timepoint: daily. Method of measurement: headache duration (days). | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug dependence reduction. Timepoint: 15 days. Method of measurement: Used Drug Dosage. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Afshin Chehreghani
Oroumia University of Medical Sciences
Outcome results
None listed